Ventyx Biosciences (VTYX) Competitors

Ventyx Biosciences (NASDAQ:VTYX) and Eton Pharmaceuticals (NASDAQ:ETON) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, community ranking, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation.

Which has more volatility & risk, VTYX or ETON?

Ventyx Biosciences has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Comparatively, Eton Pharmaceuticals has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500.

Do institutionals and insiders hold more shares of VTYX or ETON?

97.9% of Ventyx Biosciences shares are held by institutional investors. Comparatively, 27.9% of Eton Pharmaceuticals shares are held by institutional investors. 18.2% of Ventyx Biosciences shares are held by insiders. Comparatively, 14.9% of Eton Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has better earnings & valuation, VTYX or ETON?

Eton Pharmaceuticals has higher revenue and earnings than Ventyx Biosciences. Eton Pharmaceuticals is trading at a lower price-to-earnings ratio than Ventyx Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ventyx Biosciences	N/A	N/A	-$192.96M	-$1.98	-0.62
Eton Pharmaceuticals	$39.01M	9.29	-$940K	-$0.15	-90.07

Does the MarketBeat Community favor VTYX or ETON?

Eton Pharmaceuticals received 67 more outperform votes than Ventyx Biosciences when rated by MarketBeat users. Likewise, 65.77% of users gave Eton Pharmaceuticals an outperform vote while only 46.97% of users gave Ventyx Biosciences an outperform vote.

Company	Underperform	Outperform
Ventyx Biosciences	Outperform Votes 31 46.97%	Underperform Votes 35 53.03%
Eton Pharmaceuticals	Outperform Votes 98 65.77%	Underperform Votes 51 34.23%

Do analysts rate VTYX or ETON?

Ventyx Biosciences currently has a consensus price target of $10.00, suggesting a potential upside of 713.01%. Eton Pharmaceuticals has a consensus price target of $27.67, suggesting a potential upside of 104.79%. Given Ventyx Biosciences' higher possible upside, research analysts clearly believe Ventyx Biosciences is more favorable than Eton Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ventyx Biosciences	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Eton Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media prefer VTYX or ETON?

In the previous week, Eton Pharmaceuticals had 19 more articles in the media than Ventyx Biosciences. MarketBeat recorded 20 mentions for Eton Pharmaceuticals and 1 mentions for Ventyx Biosciences. Ventyx Biosciences' average media sentiment score of 1.87 beat Eton Pharmaceuticals' score of 0.57 indicating that Ventyx Biosciences is being referred to more favorably in the media.

Company	Overall Sentiment
Ventyx Biosciences	Very Positive
Eton Pharmaceuticals	Positive

Is VTYX or ETON more profitable?

Ventyx Biosciences has a net margin of 0.00% compared to Eton Pharmaceuticals' net margin of -15.81%. Eton Pharmaceuticals' return on equity of -36.29% beat Ventyx Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ventyx Biosciences	N/A	-54.94%	-50.01%
Eton Pharmaceuticals	-15.81%	-36.29%	-16.84%

Summary

Eton Pharmaceuticals beats Ventyx Biosciences on 10 of the 16 factors compared between the two stocks.